Moneycontrol PRO
Open App
Live: Live: Will Cipla Sustain Its Stellar Run?
you are here: HomeNewsIndia

Maharashtra: 15 new COVID-19 cases detected in Nashik; tally at 1,166

According to a statement issued by the district administration, reports of 15 suspected patients came out positive late on Friday night.

May 30, 2020 / 11:32 AM IST

At least 15 more persons tested positive for COVID-19 in Maharashtra's Nashik district, taking the case count to 1,166 in the region, an official said on Saturday.

According to a statement issued by the district administration, reports of 15 suspected patients came out positive late on Friday night.

The district's COVID-19 tally now stands at 1,166, of which Malegaon has recorded 763 cases, followed Nashik city at 179 and 168 reported from other parts of the region, the release stated.

As many as 56 infected persons from outside the district were also treated at hospitals here.

Among the 61 COVID-19 deaths reported in the district, 48 patients were from Malegaon, eight from Nashik city, three from other parts of the district and two from outside the district.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
A total of 786 persons have recovered from the infection in the district so far, the data stated.
first published: May 30, 2020 11:25 am
ISO 27001 - BSI Assurance Mark